BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23022425)

  • 1. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis.
    Iavarone M; Manini MA; Sangiovanni A; Fraquelli M; Forzenigo LV; Di Tommaso L; Aghemo A; Roncalli M; Ronchi G; Colombo M
    Dig Liver Dis; 2013 Jan; 45(1):43-9. PubMed ID: 23022425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT.
    Lim JH; Kim MJ; Park CK; Kang SS; Lee WJ; Lim HK
    Br J Radiol; 2004 Nov; 77(923):911-6. PubMed ID: 15507413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
    Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic hepatic nodules: radiological abnormalities and histopathological correlations.
    Ouedraogo NA; Danjoux-de-Volontat M; Auriol J; Peron JM; Rousseau H; Otal P
    Eur J Radiol; 2011 Aug; 79(2):232-6. PubMed ID: 20675086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
    O'Malley ME; Takayama Y; Sherman M
    Am J Gastroenterol; 2005 Jul; 100(7):1523-8. PubMed ID: 15984975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonography-guided percutaneous microwave ablation of high-grade dysplastic nodules in cirrhotic liver.
    Liang P; Dong B; Yu X; Wang Y; Sheng L; Yu D; Xiao Q
    AJR Am J Roentgenol; 2005 May; 184(5):1657-60. PubMed ID: 15855134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
    Caturelli E; Bartolucci F; Biasini E; Vigliotti ML; Andriulli A; Siena DA; Attino V; Bisceglia M
    Am J Gastroenterol; 2002 Feb; 97(2):397-405. PubMed ID: 11866279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study.
    Sato T; Kondo F; Ebara M; Sugiura N; Okabe S; Sunaga M; Yoshikawa M; Suzuki E; Ogasawara S; Shinozaki Y; Ooka Y; Chiba T; Kanai F; Kishimoto T; Nakatani Y; Fukusato T; Yokosuka O
    Hepatol Int; 2015 Apr; 9(2):330-6. PubMed ID: 25788204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2006 Feb; 106(3):636-47. PubMed ID: 16369988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.
    Borzio M; Fargion S; Borzio F; Fracanzani AL; Croce AM; Stroffolini T; Oldani S; Cotichini R; Roncalli M
    J Hepatol; 2003 Aug; 39(2):208-14. PubMed ID: 12873817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report.
    Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC
    Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.